Emerging Infectious Disease ISSN: 1080-6059

Histopathologic Improvement with Lymphedema Management, Léogâne, Haiti

Susan F. Wilson*, Jeannette Guarner*, Alix L. Valme†, Jacky Louis-Charles†, Tara L. Jones*, and David G. Addiss*

Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Hôpital Ste. Croix, Léogâne, Haiti

Main Article

Figure 2

Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathology in either biopsy, and boxes with a diagonal line indicate that histopathology was observed on both initial and follow-up biopsies. Boxes with an X indicate insufficient data.

Figure 2. Individual histologic responses of the 27 patients with follow-up biopsy specimens who participated in a lymphedema management program for ≈1 year. Black boxes indicate histopathologic regression or improvement, gray boxes indicate histopathologic progression or worsening, white boxes indicate the absence of histopathology in either biopsy, and boxes with a diagonal line indicate that histopathology was observed on both initial and follow-up biopsies. Boxes with an X indicate insufficient data.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.